Hunoir Pharmaceuticals bridges the gap between high-purity API nutraceutical science and evidence-based medicine in Pakistan. We research, standardize, and manufacture high-assay molecular interventions—creating a new standard of care that physicians can trust and patients can rely on for predictable outcomes.
Anchored by rigorous quantitative assay standardization, we establish a new foundation for the entire nutra-pharma sector in Pakistan. For the physician, this is clinical efficacy; for the patient, this is the security of using formulations validated by the highest global data standards.
We eliminate raw-material variability by utilizing only pharma-grade, certified active materials that meet strict USP/BP pharmacopeial limits. Our facilities are engineered to ensure that every molecule meets the highest international safety standards, providing absolute peace of mind for consumers and students.
Supported by an enterprise-grade digital framework, we ensure complete transparency across our supply chain and manufacturing pipeline. We provide open access to approved data for regulatory bodies, educational dossiers for students, and essential compliance safety information for patients.
Access accessible disease state awareness literature, simplified mechanism-of-action guides for UROX/PRONOIR, and guidelines to support your therapeutic journey.
Learn about the difference between standard supplements and API-grade, standardized assays, empowering you to make informed decisions for your health.
Explore educational monographs, clinical pathways, and foundational medical research supporting next-generation biomolecular therapeutics in Pakistan.
Anchored by the region’s first-to-market introduction of UROX for Lithiasis, our urological division continues to pioneer unintroduced metabolic and renal clearance mechanisms.
Following the unprecedented launch of PRONOIR, we are expanding our gynecological pipeline to introduce the region’s first specialized biomolecular formulations for estrogen-mediated stability and mucosal eubiosis.
Multi-modal structural interventions engineered for joint matrix integrity and cartilage preservation, guided by ESCEO and ACR endpoints.
Standardized axonal repair matrices targeting demyelination and complex peripheral neuropathic pathways.
Targeted biochemical synthesis regulating male reproductive function, endothelial health, and hormonal homeostasis.
High-assay molecular interventions supporting baseline metabolic function, immune modulation, and generalized cellular health.
Access proprietary molecular data, pharmacokinetic profiles, and standardized prescribing protocols for our targeted clinical portfolio.
Review certified safety literature, therapeutic compliance frameworks, and patient-first wellness guidelines managed by our medical affairs division.
Please enter your credentials to access proprietary API data, pharmacokinetic profiles, and clinical trial results
